IPSEN (EPA:IPN) US FDA approves Ipsen’s SohonosTM (palovarotene) capsules, the first and only treatment for people with fibrodysplasia ossificans progressiva
Transparency directive : regulatory news
16/08/2023 21:32
IPSEN's latest news
15/02/2024 10:00
13/02/2024 22:08
22/01/2024 23:00
07/12/2023 18:49
13/11/2023 22:30
06/10/2023 18:00
04/09/2023 07:00
01/09/2023 07:00
22/08/2023 18:00
16/08/2023 21:32
Other stories
29/04/2024 20:30
30/04/2024 00:24
29/04/2024 16:26
29/04/2024 20:31
30/04/2024 00:03
29/04/2024 16:01
29/04/2024 14:04
29/04/2024 13:32
29/04/2024 16:19
29/04/2024 14:36
29/04/2024 23:41
29/04/2024 13:47
30/04/2024 00:24
29/04/2024 23:46
29/04/2024 21:31
29/04/2024 16:48
29/04/2024 17:29
29/04/2024 22:03
29/04/2024 21:30
29/04/2024 13:41
29/04/2024 12:07
29/04/2024 17:50
29/04/2024 17:14
29/04/2024 18:00
29/04/2024 07:00
29/04/2024 20:22
29/04/2024 23:00
29/04/2024 22:14
29/04/2024 21:06
29/04/2024 22:41
29/04/2024 12:36
29/04/2024 13:30
29/04/2024 00:05
28/04/2024 19:21
29/04/2024 21:01
28/04/2024 12:18
29/04/2024 19:43
29/04/2024 22:05